Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?

MeSH terms

• Aged
• Bone Density Conservation Agents / adverse effects*
• Bone Neoplasms / drug therapy*
• Bone Neoplasms / secondary
• Calcium / metabolism*
• Diphosphonates / adverse effects*
• Humans
• Hypocalcemia / chemically induced*
• Imidazoles / adverse effects*
• Male
• Osteoblasts / drug effects*
• Osteoblasts / pathology
• Prostatic Neoplasms / drug therapy*
• Prostatic Neoplasms / pathology
• Treatment Outcome
• Zoledronic Acid